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ABSTRACT
Epigenetic clocks based on DNA methylation (DNAm) can accurately predict chronological age and are thought
to capture biological aging. A variety of epigenetic clocks have been developed for different tissue types and
age ranges, but none have focused on postnatal age prediction for preterm infants. Epigenetic estimators of
biological age might be especially informative in epidemiologic studies of neonates since DNAm is highly
dynamic during the neonatal period and this is a key developmental window. Additionally, markers of
biological aging could be particularly important for those born preterm since they are at heightened risk of
developmental impairments. We aimed to fill this gap by developing epigenetic clocks for neonatal aging in
preterm infants.
As part of the Neonatal Neurobehavior and Outcomes in Very Preterm Infants (NOVI) study, buccal cells were
collected at NICU discharge to profile DNAm levels in 542 very preterm infants. We applied elastic net
regression to identify four epigenetic clocks (NEOage Clocks) predictive of post-menstrual and postnatal age,
compatible with the Illumina EPIC and 450K arrays. We observed high correlations between predicted and
reported ages (0.93 – 0.94) with root mean squared errors (1.28 - 1.63 weeks).
Epigenetic estimators of neonatal aging in preterm infants can be useful tools to evaluate biological maturity
and associations with neonatal and long-term morbidities.
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INTRODUCTION
DNA methylation (DNAm) is one of the most studied
epigenetic mechanisms and acts at the interface between
the environment and human health. Changes in DNAm
are also strongly correlated with aging [1] and are
most dynamic during pediatric age [2]. Aging-related
fluctuations in DNAm levels have been capitalized on
by researchers to develop “epigenetic clocks”, sets of
CpG sites whose methylation extents have been shown
to accurately predict chronological age and are thought
to capture biological aging [2, 3]. These predicted ages
are often referred to as epigenetic age or DNAm age.
Greater DNAm age relative to chronological age, also
known as age acceleration (AA), has been shown to be
associated with age-related phenotypes in adults, such
as frailty, chronic diseases and mortality [4].
A variety of epigenetic clocks have been developed to
predict numerous age metrics in different tissue types
and age ranges [5]. One of the most widely used pantissue clocks to estimate chronological age was created
by Horvath and is based on over 8,000 samples from 51
healthy tissues (age range: 0-101 years) [6]. However,
DNAm age estimates from Horvath’s epigenetic clock
become more precise as chronological age increases and
are most variable in pediatric samples [7]. Hannum et
al. developed a clock based on blood with an age range
of 19-101 years [8] while other clocks are designed
to capture physiological measures of biological age
rather than chronological age. These include DNAm
PhenoAge [9] and DNAm GrimAge [10] and are both
blood-based. Many studies have successfully generated
epigenetic clocks for various tissues, age ranges, and
morbidities, leading to very promising predictors of
chronological age in adults, and to potentially useful

biomarkers for the diseases of aging. While some
epigenetic clocks include children, most clocks are
primarily focused on adults and extrapolating them to
children results in inaccurate predictions [2, 11].
Additionally, AA metrics that are derived from these
clocks may not be as relevant to the health conditions
that are most important to children and adolescents. To
address this issue McEwen et al. developed PedBE,
an epigenetic clock that focuses on estimating
chronological age of children ranging from 0 (birth) to
20 years old and is based on buccal epithelial cells [2].
However, the definition of chronological age becomes
less meaningful proximal to birth and is especially
skewed among infants born preterm. Infants born
preterm might differ biologically from infants of the
same chronologic or postnatal age that are born fullterm. Epigenetic clocks, such as those developed by
Knight et al. [12] or Bohlin et al. [13], have been
created to capture gestational age (GA), i.e. the time
from conception to birth. Both clocks are based on cord
blood and therefore can only estimate GA, not postnatal
age. To our knowledge, there exists no epigenetic clock
that properly handles or is specialized for age prediction
in preterm infants.
The WHO estimated 15 million infants, approximately
10% of live births, are born prematurely early every
year (before completing 37 weeks of gestation) [14].
Preterm birth is not only associated with acute and longterm morbidities including chronic illnesses, brain
injuries, and adverse neuromotor, cognitive, and
behavioral outcomes [15], but it is also the leading
cause of death worldwide among children under 5 years
[14]. This leads to an immense emotional and financial
burden for families and society. The Institute of
Medicine reported in 2007 that the average medical

Figure 1. Illustration of different perinatal age metrics, measured in weeks and days, which we highlight for infants born
preterm. Gestational age (GA) is defined as the time from conception to birth (expected delivery around 37-42 weeks typically refers to fullterm birth, and <37 weeks refers to preterm birth). Post-menstrual age (PMA) refers to the time from conception onward, and postnatal age
(PNA) is equivalent to chronological age and is the time elapsed after birth. In this study, buccal cell tissue was collected from infants at NICU
discharge to profile DNA methylation.
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costs of the first year were almost 10 times greater for
preterm infants in the U.S., and results in a societal
economic cost of $26.2 billion each year [16, 17].

Infants (NOVI) data set (buccal cells) and an external
saliva data set.
NEOage clocks

Here, we present four NEOage (Neonatal Epigenetic
Estimator of age) clocks, epigenetic clocks that are
focused on age estimation of preterm infants based on
their DNAm profile measured in an easily accessible
tissue, buccal epithelial cells. Specifically, we
investigated post-menstrual age (PMA), the time from
conception to tissue collection at neonatal intensive care
unit (NICU) discharge, and post-natal age (PNA, or
chronological age), the time from birth to tissue
collection (Figure 1). These epigenetic estimators of
aging could be particularly important for preterm
neonates because they may provide insight into early
life aging, reflect health and development, and provide a
measure of early life risk for neonatal morbidities or
long-term neurodevelopmental impairments.

RESULTS
We applied elastic net regression to identify the sets of
CpGs that are predictive of PMA and PNA in a unique
population of 542 preterm neonates (see Table 1 for
characteristics of the study sample). We compared the
prediction performances of our NEOage clocks to two
existing epigenetic clocks (Horvath’s skin-blood clock
and PedBE) by evaluating their performances in our
Neonatal Neurobehavior and Outcomes in Very Preterm

We identified four epigenetic clocks predictive of either
PMA or PNA that are compatible with the Infinium
MethylationEPIC BeadChip (EPIC) array or Infinium
HumanMethylation450 BeadChip (450k) array. The
number of CpGs within each clock range from 303-522
CpGs with varying degrees of overlap between the
clocks (see Figure 2). CpGs for each NEOage clock
with the corresponding coefficients to calculate DNAm
age are provided in the Supplementary Material
(Supplementary Tables 1–4 and Supplementary Code 1).
To assess the prediction performances without reusing
information we performed leave-one-out (LOO) crossvalidation (additional information in 5.3 Development
of the epigenetic clock) and evaluated prediction
performances using correlations and root mean squared
ˆi )2
N (x − x
error ( RMSE =  i =1 i
with xi and xˆi being
N
the observed and estimated age, respectively). We
observed very strong positive correlations between
predicted and measured age metrics (r > 0.9 and
p-values < 10−16) with very similar correlation
coefficients among our four NEOage clocks (Figure 3).
The predictions for PMA achieved RMSEs of 1.28 for

Table 1. Characteristics of the study population (N=542).
Sample characteristics
Infant sex
Male
Female
Race and Ethnicity
White
Black
Asian
Hawaiian / Pacific Islander
Other
Ethnicity
Non-Hispanic
Hispanic
PMA (weeks)
PNA (weeks)
Gestational age (weeks)
Birthweight (grams)
Maternal age (years)
Serious infection
Bronchopulmonary dysplasia
Severe brain injury
Retinopathy

N (%) / Median (IQR)
301 (55.5)
241 (44.5)
280 (52.2)
123 (22.9)
41 (7.6)
38 (7.1)
54 (10.1)
419 (78.2)
117 (21.8)
38.57 (4.43)
11.43 (6.39)
27.29 (3.14)
919 (430)
28.50 (9.25)
103 (19.11)
277 (51.39)
69 (12.80)
34 (6.31)

PMA, postmenstrual age; PNA, postnatal age.
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Figure 2. Upset plot of CpGs included in our four NEOage clocks. Highlighted in red are the number of CpGs that are unique to each
individual clock. Highlighted in orange are the number of overlapping CpGs of clocks that are predictive of either PMA or PNA. Highlighted in
blue are the number of CpGs that overlapped in all four clocks (additional information for the 20 common CpGs provided in Supplementary
Table 13). Highlighted in black are the number of overlapping CpGs of clocks where at least one clock is predictive of PMA and at least one
clock is predictive of PNA.

the 450k and EPIC clocks, while predictions of PNA
resulted in a RMSEs of 1.63 and 1.55, for the 450k and
EPIC clocks respectively. The scatterplots in Figure 3 in
combination with the strong correlations and low
RMSE indicate high accuracy of our NEOage clocks.
Next, we evaluated the prediction performance of our
450k clocks in an external independent data set that
measured DNAm in saliva tissue using the 450k array.
This external saliva data (GSE72120 [18]) includes
preterm (n=34) and full-term infants (n=14) for which
PMA (median = 40.15; IQR = 2.61 weeks) and PNA
(median = 9.79; IQR = 7.64) were available. While
Figure 4 visualizes both preterm and full-term infants,
we first focused on only preterm infants in the
prediction performance assessment of our NEOage
clocks. Focusing on preterm infants of the saliva data
allows for a more appropriate comparison of the two
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data sets. The prediction performances in the external
saliva data set resulted in diminished but still strong
correlations (PMA: r=0.61 and PNA: r=0.76), and lower
RMSE for PMA (RMSE = 1.09) and similar RMSE for
PNA (RMSE = 1.55), compared to the NOVI data set.
However, it is important to note that the ranges of PMA
and PNA in preterm infants of the saliva data are 3842.6 and 6.9-17.6 weeks, respectively. These ranges are
noticeably smaller than the ranges of PMA and PNA in
the NOVI data set (PMA: 32.1-51.4 weeks; PNA: 2.725.3 weeks) and is likely one reason for lower
correlation coefficients between predicted and reported
ages in this dataset.
While we observed strong predictive performance for
our newly developed NEOage clocks, the existing
Horvath skin-blood clock and PedBE clock did not
predict PNA as accurately in preterm infants. As shown
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Figure 3. Scatterplots of estimated and measured age. Prediction performances are evaluated by RMSE and correlations
between estimated and measured age metrics. (A) Scatterplots of estimated and measured PMA using our 450k NEOage clocks within
NOVI. (B) Scatterplots of estimated and measured PNA using our 450k NEOage clocks within NOVI. ( C) Scatterplots of estimated and
measured PMA using our EPIC NEOage clocks within NOVI. (D) Scatterplots of estimated and measured PNA using our EPIC NEOage
clocks within NOVI.

Figure 4. Scatterplots of estimated and measured age using our 450k NEOage clocks in an external saliva data set (GSE72120
[18]) that included full-term (red) and preterm (blue) infants. This saliva data set was measured by the 450k array. The reported
prediction performances, RMSE and correlation coefficients between estimated and measured age metrics are based on preterm infants
only, since our NOVI training data did not include any full-term infants. (A) Scatterplots of estimated and measured PMA. (B) Scatterplots of
estimated and measured PNA.
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in Figure 5, the correlations between estimated and
measured PNA are moderate in the NOVI data set
(Horvath: r = 0.44 and PedBE: r = 0.59). The RMSE are
greater for both clocks, with a noticeably greater RMSE
for Horvath’s skin-blood clock (Horvath: RMSE = 49.68
and PedBE: RMSE = 8.68). Additionally, our NEOage

clocks outperformed the existing clocks in the
independent saliva data set. Analogously, Figure 6
displays both preterm and full-term infants. For preterm
infants (highlighted in blue), Horvath skin-blood clock
and PedBE exhibit weak correlations (Horvath: r = 0.31
and PedBE: r = 0.19) with RMSE of 38.49 and 12.93

Figure 5. Scatterplots of PNA estimated by (A) Horvath’s skin-blood clock and (B) PedBE and measured PNA within NOVI. Prediction
performances are evaluated by RMSE and correlations between estimated and measured PNA.

Figure 6. Scatterplots of measured PNA and PNA estimates by (A) Horvath’s skin-blood clock and (B) PedBE in an external saliva data set
(GSE72120 [18]). This saliva data set was measured by the 450k array and included full-term (red) and preterm (blue) infants. The reported
prediction performances, RMSE and correlation coefficients, between estimated and measured age metrics are based on preterm infants
only.
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weeks, respectively. For full-term infants (highlighted
in red), the Horvath skin-blood clock correlation is r =
0.60 and PedBE correlation is r = 0.20 with RMSE of
46.31 and 5.54 weeks, respectively. Interestingly,
Horvath’s clock yields a substantially better correlation
between reported and predicted age for full-term infants
compared to preterm infants, while the PedBE clock
yielded weak correlations for both groups. Yet, while
the correlations are stronger for Horvath’s clock, the
actual predicted ages were closer to the reported ages for
the PedBE clocks. In contrast, PNA prediction of fullterm infants using our NEOage 450k PNA clock has a
stronger correlation (r = 0.76) than both existing clocks
and a similar RMSE of 7.42 weeks compared to PedBE.
The best prediction performance for the full-term infants
resulted from our NEOage 450k PMA clock with a
correlation of 0.90 and RMSE of 2.14 weeks.

A systematic deviation of full-term infants can be
observed in Figures 4, 6. This shift appears to be
more dominant in PNA predictions and might indicate
that our PMA and PNA clocks capture a similar
aging signature, but that our PNA clocks are more
sensitive to the GA at birth. Pre- and full-term infants,
as shown in Figure 4B, appear to have moderately
similar regression slopes, but different intercepts,
which is most likely a result of their different GA at
birth. While extrapolation of our NEOage clocks
outside of their training range is not recommended, it
can be expected that prediction accuracy decreases
with greater age differences (similar to extrapolating
adult clocks to children, or pediatric clocks to the
neonatal period). However, if extrapolation of age
outside of our training age range but proximal to birth
is necessary, our PMA clocks might be more
appropriate.

Enrichment analysis
We performed enrichment analyses for the CpGs
included in the four NEOage clocks that we
characterized to evaluate potential pathway enrichments
of genes associated with CpGs that we identified. No
pathways or gene ontology (GO) terms were
significantly enriched after False Discovery Rate
(FDR) correction (FDR < 0.1), but the KEGG (Kyoto
Encyclopedia of Genes and Genomes) pathways
and GO terms that tended to have the smallest
raw p-values included immune and inflammatory
responses, endocrine activities, steroidogenesis, cellular
proliferation, cellular differentiation and organization,
and organ morphogenesis. Tables containing the
20 most significantly enriched pathways are provided
in the Supplementary Material (Supplementary Tables
5–12).

DISCUSSION
While there has been some progress in addressing
the lack of epigenetic clocks focusing on pediatric
populations in recent years [2], to our knowledge, there
currently exists no epigenetic clock that is specialized
for preterm infants, nor for age prediction specific to the
neonatal period. Preterm infants present a unique
population due to the shift of their biological and
chronological age progress relative to full-term infants.
To fill this gap, we developed four NEOage clocks that
are based on preterm infants from the NOVI study to
estimate PMA and PNA (EPIC- and 450k-compatible)
and include 303-522 CpGs. We demonstrate that our
newly developed NEOage clocks outperform two
established epigenetic clocks, Horvath’s skin-blood
clock and PedBE, both in our NOVI buccal data set and
in an external saliva data set of infants that were born
preterm.
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We observed noticeable differences in RMSE when
comparing reported ages to predicted ages from
existing clocks [2, 6], predominantly in estimates
from Horvath’s skin-blood clock, but also PedBE.
One possible explanation is that both clocks were not
specifically developed for this age range. For these
existing clocks, age is estimated in years, which was
then transformed to weeks by multiplying by 52.
Hence, any prediction errors might be amplified. In
addition, PNA is greatly overestimated for all infants
by Horvath’s skin-blood clock, meaning that
estimated PNA is greater than measured PNA for
every infant.
While PMA seems to provide a more generalizable
estimate of age, it comes with the limitation that the day
of conception (reference point to calculate PMA) is not
as precise of a measurement as day of birth (reference
point to calculate PNA) and therefore is associated with
a certain degree of uncertainty. Another limitation is the
extension of these clocks to other tissue types, because
our NEOage clocks are based on buccal cells collected
via cheek swabs from preterm infants. Generalizing our
NEOage clock to different tissue types will most likely
compromise the prediction performance. Nevertheless,
buccal swab is minimally invasive and thus is
specifically important in pediatric and neonatal
populations where more invasive sampling may deter
study participation [19]. While blood samples provide
large amounts of DNA with good quality, it requires an
invasive and expensive procedure with technical
difficulties, can be difficult or impossible to collect
from preterm neonates, and causes discomfort and
increased risk of infection [19]. In addition, buccal
epithelial cells have been shown to be better proxy for
the brain than peripheral blood [20]. The collection of
buccal cells and saliva is less complicated, inexpensive
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and non-invasive [19], with the added benefit of buccal
cells being less heterogeneous [2, 20]. A possible
contamination of prenatal fetal sample with maternal
cells can be avoided by performing a short terminal
repeats analysis [19].
With our newly developed NEOage clocks we aim to
fill the gap of methylation clocks trained on pediatric
samples [21] and based on buccal cells, an easily
accessible tissue that requires no invasive procedures.
Our epigenetic estimators of neonatal aging in preterm
infants might be particularly valuable in this population
of neonates because it could allow us to gain insight
into early life aging and reflect influences on
subsequent health and development. Further,
establishing precise estimators of PMA might help us to
develop tools to more accurately determine the day of
conception and measurements associated with it (e.g.,
PMA and GA).

including central nervous system, cardiovascular,
gastrointestinal, genitourinary, chromosomal, and
nonspecific anomalies, and NICU death. Parents of
eligible infants were invited to participate in the study
when survival to discharge was determined to be likely
by the attending neonatologist. Overall, 704 eligible
infants were enrolled. Researchers explained study
procedures and obtained informed consent in accordance
with each institution’s review board. 542 children for
which DNAm data was measured and passed QC were
included in this analysis (characteristics presented in
Table 1). The sample included 19% of infants with
serious infection (sepsis or necrotizing enterocolitis),
51% with bronchopulmonary dysplasia, 13% with severe
brain injury (parenchymal echodensity, periventricular
leukomalacia, or ventricular dilatation), and 6% with
severe retinopathy of prematurity. PMA in NOVI was
calculated by adding PNA at buccal collection to the
estimated GA at birth which was obtained via an
established process [22, 23] and is described in detail by
Everson et al. [15].

CONCLUSIONS
DNAm collection and pre-processing
We have introduced our four NEOage clocks that are
specific to the assessment of epigenetic age in very
preterm neonates. Our NEOage clocks are based on
buccal cells, a tissue that is easily accessible and requires
no invasive intervention. Postmenstrual age (PMA) and
post-natal age (PNA) can be accurately estimated
utilizing DNAm measured by either the Illumina 450k or
EPIC array. We demonstrated that our NEOage clocks
outperform two existing clocks by assessing their
prediction performances in two preterm infant data sets.
With our NEOage clocks, we have provided tools to
examine neonatal aging, age acceleration and their
association with neonatal health and development in a
unique population of very preterm infants.

MATERIALS AND METHODS
Study participants
The Neonatal Neurobehavior and Outcomes in Very
Preterm Infants (NOVI) Study was conducted at 9
university-affiliated NICUs in Providence, RI, Grand
Rapids, MI, Kansas City, MO, Honolulu, HI, WinstonSalem, NC, and Torrance and Long Beach CA from
April 2014 through June 2016. These NICUs were also
Vermont Oxford Network (VON) participants.
Eligibility was determined based on the following
inclusion criteria: 1) birth at <30 weeks post menstrual
age; 2) parental ability to read and speak English or
Spanish and 3) residence within 3 hours of the NICU
and follow-up clinic. Exclusion criteria included
maternal age <18 years, maternal cognitive impairment,
maternal death, infants with major congenital anomalies,
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Buccal cell tissue was collected from infants that were
born very preterm (<30 weeks gestation), at NICU
discharge (Figure 1), and DNAm levels were profiled
using the EPIC array.
Genomic DNA was extracted from buccal swab
samples, collected near term-equivalent age, using the
Isohelix Buccal Swab system (Boca Scientific),
quantified using the Quibit Fluorometer (Thermo
Fisher, Waltham, MA, USA) and aliquoted into a
standardized concentration for subsequent analyses.
DNA samples were plated randomly across 96-well
plates and provided to the Emory University Integrated
Genomics Core for bisulfite modification using the EZ
DNA Methylation Kit (Zymo Research, Irvine, CA,
USA), and subsequent assessment of genome-wide
DNAm using the Illumina MethylationEPIC Beadarray
(Illumina, San Diego, CA, USA) following standardized
methods based on the manufacturer’s protocol. The preprocessing of the data followed a modified workflow
described by Everson et al. [15]. Array data were
normalized via Noob normalization [24, 25] and
samples with more than 5% of probes yielding detection
p-values > 1.0E-5 or mismatch between reported and
predicted sex were excluded. In addition, one of two
duplicated samples was omitted (we retained the
duplicate sample with smallest detection p-values).
Probes with median detection p-values < 0.05, probes
measured on the X or Y chromosome, probes that had
single nucleotide polymorphisms (SNP) within the
binding region or that could cross-hybridize to other
regions of the genome were excluded [26]. Then, array
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data were standardized across Type-I and Type-II probe
designs with beta-mixture quantile normalization [27,
28]. After exclusions, 706,323 probes were available
from 542 samples for this study. These data are
accessible through NCBI Gene Expression Omnibus
(GEO) via accession series GSE128821.

EPIC array and the other profiled DNAm in saliva using
the 450k array. We evaluated the performance of our
PMA-450k and PNA-450k NEOage clocks in the test
sample by examining the correlation between predicted
and measured outcomes. We also report the RMSE.
Application of existing epigenetic clocks

Development of the epigenetic clocks
Since data from the EPIC and 450k arrays are widely
used in ongoing research projects, we considered two
sets of data for all analyses: (1) a complete data set
(706,323 probes) with logit transformed beta-values (mvalues) that is compatible with EPIC arrays (hereafter
referred to as the EPIC data set) and (2) a subset of the
logit-transformed data (364,410 probes) that is
compatible with both EPIC and 450k arrays (hereafter
referred to as the 450k data set). Penalized regression
models (“glmnet” function in glmnet R package [29])
were fit to both data sets to identify sets of CpGs
(NEOage clocks) predictive of PMA and PNA (4 total
clocks: PMA-EPIC, PNA- EPIC, PMA-450k and PNA450k). The alpha parameter of glmnet was set to 0.5
(elastic net regression) and lambda (PMA-EPIC: 0.049,
PNA- EPIC: 0.0677, PMA-450k: 0.097 and PNA-450k:
0.2038) was chosen such that the mean cross-validated
error is minimized with 10-fold cross validation
(“lambda.min” result from “cv.glmnet” function in
glmnet R package [29]).
We fit a series of penalized regression models to both
data sets (EPIC and 450k) applying LOO crossvalidation. This procedure allowed us to assess
prediction performances but also limit overfitting and
selection bias. In LOO cross-validation, a model is
trained on all but one sample to make a prediction for
that held-out sample. This step is repeated until each
sample is held out and predicted once and results in N
potentially unique sets of CpGs for a given outcome,
where N is the sample size. Because our sample
contained multiple births (e.g., twins), we additionally
removed all siblings from the training set of all nonsingleton children. The performance of predicted age
outcomes was evaluated by examining their correlation
with the measured outcome and RMSE.
In addition, prediction performances of models trained
using the complete (not LOO approach) 450k data set
(450k NEOage clocks) were evaluated in an
independent publicly available data set (GSE72120
[18]) that contained DNAm from the 450k array for 34
preterm and 14 full-term infants with information on
PMA and PNA. This data set was chosen because to our
knowledge it is the closest comparable data, but it is
important to point out the difference between both data
sets, as one measured DNAm of buccal swabs via the
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To compare our newly-developed NEOage clocks to
existing clocks, we applied Horvath’s skin-blood clock
[30] and the PedBE clock [2] to estimate PNA in our
data and in the independent external data set. Both
existing clocks were trained on pediatric epithelial
samples, and thus could be applicable to our data.
However, the skin-blood clock was also trained on
blood samples and thus can estimate age from DNA
derived from multiple tissue types, while PedBE is
specific to buccal epithelium. Additionally, while the
skin-blood clock is a life-course clock that was trained
on samples from infants, children, and adults, the
PedBE clock is a pediatric-specific clock. The
coefficients and codes for estimating age via these
existing clocks are available in the original publications
via the Supplementary Materials [30] and the author’s
webpage [2]. Horvath’s skin-blood clock includes 391
CpGs and was developed with DNA from human
fibroblasts, keratinocytes, buccal cells, endothelial cells,
blood, and saliva (age range: 0-92 years). Out of the 391
CpGs, 345 CpGs were available in the NOVI and saliva
data set. For the NOVI data set, 42 out of the 46 missing
CpGs were substituted with closest CpGs within
5,000bp. The remaining 4 missing CpGs were omitted;
3 CpGs did not have CpGs available in our data that
were within 5,000bp and 1 CpG was located on
chromosome X (excluded during data preprocessing).
Analogously for the saliva data set, 40 of the 46 missing
CpGs were substituted with closest CpGs within
5,000bp. The remaining 6 missing CpGs were omitted;
5 CpGs did not have CpGs available in the saliva data
set that were within 5,000bp and 1 CpG was located on
chromosome X. The PedBE clock (age range: 0-20
years), developed with pediatric buccal epithelial cells,
consists of 94 CpGs. There were 5 CpGs not available
in the NOVI and saliva data set, which were substituted
by the closest CpGs within 5,000bp. No CpGs were
omitted. Performance of predicted PNA was evaluated
by their correlation with the measured PNA and RMSE.
Enrichment analysis
To gain insights into the biological functions of the
genes associated with the identified CpGs included in
the four NEOage clocks, we performed an enrichment
analysis. We utilized the “gometh” function in
missMethyl Bioconductor package [31], that performs a
hypergeometric test, while taking the number of CpG
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sites per gene into account. For the enrichment analysis
involving the CpGs of our 450k NEOage clocks, we
specified the array type to be “450k” and provided a list
of CpGs that were considered (364,410 probes) for the
“all.cpg” argument of “gometh”. Analogously, we
specified the array type to be “EPIC” for the enrichment
analysis involving the CpGs of our EPIC NEOage
clocks and provided a list of CpGs that were considered
(706,323 probes). We evaluated both options for
databases provided by “gometh”: GO and KEGG.
Data availability statement
The DNA methylation data generated in the current
study are available in the NCBI GEO via accession
series GSE128821. R codes used for the analyses
presented in the paper are available upon request to the
corresponding author.
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SUPPLEMENTARY MATERIALS
Supplementary Tables
Please browse Full Text version to see the data of Supplementary Tables 1–4.

Supplementary Table 1. CpGs and corresponding coefficients of the 450k-PMA NEOage clock.

Supplementary Table 2. CpGs and corresponding coefficients of the 450k-PNA NEOage clock.

Supplementary Table 3. CpGs and corresponding coefficients of the EPIC-PMA NEOage clock.

Supplementary Table 4. CpGs and corresponding coefficients of the EPIC-PNA NEOage clock.

Supplementary Table 5. Top 20 pathways from GO pathway analysis for CpGs included in the 450k-PMA
NEOage clock.
GO:0051240
GO:0007343
GO:0071230
GO:0120162
GO:0005086
GO:0032011
GO:0032012
GO:0043200
GO:0031669
GO:0098772
GO:0051239
GO:0002687
GO:0031668
GO:0071496
GO:0051954
GO:0045623
GO:0106106
GO:0120161
GO:0042636
GO:0009966

ONTOLOGY

TERM

N

DE

P.DE

FDR

BP
BP
BP
BP
MF
BP
BP
BP
BP
MF
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP

positive regulation of multicellular organismal process
egg activation
cellular response to amino acid stimulus
positive regulation of cold-induced thermogenesis
ARF guanyl-nucleotide exchange factor activity
ARF protein signal transduction
regulation of ARF protein signal transduction
response to amino acid
cellular response to nutrient levels
molecular function regulator
regulation of multicellular organismal process
positive regulation of leukocyte migration
cellular response to extracellular stimulus
cellular response to external stimulus
positive regulation of amine transport
negative regulation of T-helper cell differentiation
cold-induced thermogenesis
regulation of cold-induced thermogenesis
negative regulation of hair cycle
regulation of signal transduction

1717
5
63
96
18
18
18
106
223
1668
3091
120
254
322
34
15
140
140
5
2976

55.5
2
7
8
4
4
4
8
11
45
80
7
12
14
4
3
9
9
2
75.33333333

0.000101530604212178
0.000488637355841379
0.000539308264807122
0.000645109263846585
0.000719253481406075
0.00124599435874616
0.00124599435874616
0.00126159591846291
0.00174701422017418
0.00185581614546516
0.00185939492722176
0.00199912401286309
0.00200618606306946
0.00209524302848006
0.00234424561108088
0.00247101470290018
0.00249643374976729
0.00249643374976729
0.00301157639678554
0.00329481415897157

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
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Supplementary Table 6. Top 20 pathways from KEGG pathway analysis for CpGs included in the 450k-PMA
NEOage clock.
path:hsa04974
path:hsa04144
path:hsa04512
path:hsa04151
path:hsa00450
path:hsa04972
path:hsa04971
path:hsa04150
path:hsa04640
path:hsa04727
path:hsa03410
path:hsa04064
path:hsa00500
path:hsa04510
path:hsa04261
path:hsa05412
path:hsa05200
path:hsa00920
path:hsa04657
path:hsa03022

Description

N

DE

P.DE

FDR

Protein digestion and absorption
Endocytosis
ECM-receptor interaction
PI3K-Akt signaling pathway
Selenocompound metabolism
Pancreatic secretion
Gastric acid secretion
mTOR signaling pathway
Hematopoietic cell lineage
GABAergic synapse
Base excision repair
NF-kappa B signaling pathway
Starch and sucrose metabolism
Focal adhesion
Adrenergic signaling in cardiomyocytes
Arrhythmogenic right ventricular cardiomyopathy
Pathways in cancer
Sulfur metabolism
IL-17 signaling pathway
Basal transcription factors

92
242
86
331
17
93
75
151
89
84
32
95
30
193
144
74
506
10
88
41

7
12.5
6
13.5
2
5
5
7
4
5
2.5
4
2
8
6
4
15
1
3
2

0.0025432527716253
0.00483311842154896
0.0131031855183759
0.0218884783349282
0.0265841978233973
0.0269679372038782
0.0273248262064296
0.0374334371410264
0.0462122030513505
0.0469447204065581
0.0642826135929407
0.0737709112366848
0.0746391342946885
0.0828799780172142
0.0930959869894971
0.106935318655637
0.109313257881781
0.111928784033015
0.120766341082755
0.122128583254498

0.826463250084872
0.826463250084872
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Supplementary Table 7. Top 20 pathways from GO pathway analysis for CpGs included in the 450k-PNA NEOage
clock.
ONTOLOGY

TERM

N

DE

P.DE

FDR

GO:0042127
GO:0008283
GO:0008285

BP
BP
BP

1591
1897
715

40
44
23

0.0000534190886299528
0.000139796711649994
0.000144783294410145

1
1
1

GO:0090191

BP

2

2

0.000224072825185314

1

GO:2001252
GO:0031616
GO:0033044
GO:0045843
GO:1901187
GO:0048635
GO:0097028
GO:0060021
GO:1901862
GO:0030513
GO:0016202
GO:0048385
GO:0045082
GO:0070534
GO:0048634
GO:1901861

BP
CC
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP
BP

regulation of cell population proliferation
cell population proliferation
negative regulation of cell population proliferation
negative regulation of branching involved in ureteric bud
morphogenesis
positive regulation of chromosome organization
spindle pole centrosome
regulation of chromosome organization
negative regulation of striated muscle tissue development
regulation of ephrin receptor signaling pathway
negative regulation of muscle organ development
dendritic cell differentiation
roof of mouth development
negative regulation of muscle tissue development
positive regulation of BMP signaling pathway
regulation of striated muscle tissue development
regulation of retinoic acid receptor signaling pathway
positive regulation of interleukin-10 biosynthetic process
protein K63-linked ubiquitination
regulation of muscle organ development
regulation of muscle tissue development

164
14
323
55
2
56
38
88
58
32
143
16
4
49
147
146

9.5
3
12.5
5
2
5
4
7
5
4
8
3
2
4
8
8

0.000246284844795411
0.000330509425042432
0.000664900082049856
0.000970314025106637
0.000971984410108729
0.00108076577962778
0.00125990537999378
0.00141641819931624
0.00153736679951646
0.00161955302866369
0.00163674469616389
0.00165543877096897
0.00168336883391311
0.00175553877998935
0.0019218112555276
0.00194065212296168

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

www.aging-us.com

23540

AGING

Supplementary Table 8. Top 20 pathways from KEGG pathway analysis for CpGs included in the 450k-PNA
NEOage clock.
Description
Ovarian steroidogenesis
Insulin secretion
Sulfur metabolism
Arginine and proline metabolism
Fc epsilon RI signaling pathway
Alanine, aspartate and glutamate metabolism
Ubiquitin mediated proteolysis
Adrenergic signaling in cardiomyocytes
Calcium signaling pathway
Metabolic pathways
Amino sugar and nucleotide sugar metabolism
Acute myeloid leukemia
Aldosterone synthesis and secretion
Vasopressin-regulated water reabsorption
Arachidonic acid metabolism
Cortisol synthesis and secretion
Vibrio cholerae infection
Complement and coagulation cascades
Nitrogen metabolism
Cholinergic synapse

path:hsa04913
path:hsa04911
path:hsa00920
path:hsa00330
path:hsa04664
path:hsa00250
path:hsa04120
path:hsa04261
path:hsa04020
path:hsa01100
path:hsa00520
path:hsa05221
path:hsa04925
path:hsa04962
path:hsa00590
path:hsa04927
path:hsa05110
path:hsa04610
path:hsa00910
path:hsa04725

N
50
83
10
46
66
36
132
144
228
1400
47
64
95
43
61
63
49
81
15
111

DE
3
4
1
2
3
2
4
5
7
21.5
2
3
4
2
2
3
2
2
1
4

P.DE
0.0305045691205889
0.0580354487974986
0.0635494328977979
0.0660623210263602
0.0689829305658202
0.0691860293452126
0.0765639489819126
0.0797431390863962
0.0802610307505027
0.0827951900967627
0.0837183667094073
0.0853382746769124
0.0941511750167515
0.0958227630574678
0.0990080964986279
0.103475903215217
0.139903479319178
0.144076070674707
0.144600617616157
0.144777378086761

FDR
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Supplementary Table 9. Top 20 pathways from GO pathway analysis for CpGs included in the EPIC-PMA NEOage
clock.
ONTOLOGY

TERM

N

DE

P.DE

FDR

GO:0060090

MF

244

19.5

0.0000261984905881029

0.299312820997077

GO:0030674

MF

204

17.5

0.0000264948943079647

0.299312820997077

GO:0009653
GO:0061061
GO:0071149
GO:0060187
GO:0043005
GO:0001725
GO:0097517

BP
BP
CC
CC
CC
CC
CC

2628
649
2
2
1245
66
66

93.3333333333333
30
2
2
51
8
8

0.00036075400639525
0.000817243519837221
0.000829613936436568
0.00124016610690871
0.00135112812526085
0.00149094428870597
0.00149094428870597

1
1
1
1
1
1
1

GO:2000096

BP

8

3

0.00164092892480337

1

GO:0034330
GO:0019215
GO:0032432

BP
MF
CC

629
14
72

32
3
8

0.00190548862751066
0.00192713729059663
0.00213251244179354

1
1
1

GO:0032289

BP

3

2

0.00247281453328891

1

GO:0090258

BP

3

2

0.0026011582719471

1

GO:0003012
GO:0044297
GO:1904636
GO:1904637

BP
CC
BP
BP

457
537
4
4

21.8333333333333
25.5
2
2

0.00276093280594124
0.0030219067814788
0.00306956109657764
0.00306956109657764

1
1
1
1

GO:0071936

MF

molecular adaptor activity
protein-macromolecule adaptor
activity
anatomical structure morphogenesis
muscle structure development
TEAD-2-YAP complex
cell pole
neuron projection
stress fiber
contractile actin filament bundle
positive regulation of Wnt signaling
pathway, planar cell polarity pathway
cell junction organization
intermediate filament binding
actin filament bundle
central nervous system myelin
formation
negative regulation of mitochondrial
fission
muscle system process
cell body
response to ionomycin
cellular response to ionomycin
coreceptor activity involved in Wnt
signaling pathway

8

3

0.00306994667197237

1
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Supplementary Table 10. Top 20 pathways from KEGG pathway analysis for CpGs included in the EPIC-PMA
NEOage clock.
path:hsa04310
path:hsa03022
path:hsa04150
path:hsa04514
path:hsa04916
path:hsa04750
path:hsa04971
path:hsa00780
path:hsa04744
path:hsa00630
path:hsa04625
path:hsa05146
path:hsa05205
path:hsa00515
path:hsa03410
path:hsa04144
path:hsa05031
path:hsa04152
path:hsa04080
path:hsa04070

Description
Wnt signaling pathway
Basal transcription factors
mTOR signaling pathway
Cell adhesion molecules
Melanogenesis
Inflammatory mediator regulation of TRP channels
Gastric acid secretion
Biotin metabolism
Phototransduction
Glyoxylate and dicarboxylate metabolism
C-type lectin receptor signaling pathway
Amoebiasis
Proteoglycans in cancer
Mannose type O-glycan biosynthesis
Base excision repair
Endocytosis
Amphetamine addiction
AMPK signaling pathway
Neuroactive ligand-receptor interaction
Phosphatidylinositol signaling system

N
160
41
151
133
101
97
75
3
27
30
103
98
199
23
32
244
66
117
320
92

DE
11
3
8
7
6
6.5
5
1
2
2
5
5
9
2
2.5
10
4
6
9.16666666666667
5

P.DE
0.00563804820140634
0.0382585766688834
0.0409548512453372
0.055839619373039
0.0575374173755753
0.0678487404242832
0.0701572968381165
0.0745147803124464
0.080805733488801
0.0970358200187176
0.0984908711417847
0.0985952263276953
0.0989759531598264
0.0996538362015267
0.101507997479545
0.102761294195724
0.107648802928742
0.109755427511973
0.125111384608538
0.12605022083487

FDR
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Supplementary Table 11. Top 20 pathways from GO pathway analysis for CpGs included in the EPIC-PNA
NEOage clock.
ONTOLOGY

TERM

N

DE

P.DE

FDR

GO:0110111

BP

33

7

0.0000150081855686758

0.339094944738661

GO:1905331

BP

16

5

0.0000864716932197235

0.951641205696613

GO:0060686
GO:0030510

BP
BP

4
88

3
9

0.000172823666721358
0.000218810440561404

0.951641205696613
0.951641205696613

GO:0090191

BP

2

2

0.000250881472848229

0.951641205696613

GO:0048645
GO:0060685
GO:0060688
GO:0090192
GO:0072283
GO:0030509
GO:0032675
GO:0005402
GO:0090185

BP
BP
BP
BP
BP
BP
BP
MF
BP

63
5
53
14
14
146
143
19
16

8.5
3
7
4
4
11
9
4
4

0.000320898779391021
0.000364936681518837
0.000371355157976279
0.000382316795422211
0.000504258477605173
0.000555551138375544
0.000582041777636664
0.000606490301815559
0.000644477997689534

0.951641205696613
0.951641205696613
0.951641205696613
0.951641205696613
0.951641205696613
0.951641205696613
0.951641205696613
0.951641205696613
0.951641205696613

GO:0047045

MF

4

2

0.000704248067798324

0.951641205696613

GO:2000343

BP

9

3

0.000725385020377788

0.951641205696613

GO:0032755
GO:0030432
GO:0072006
GO:0030513

BP
BP
BP
BP

negative regulation of animal organ morphogenesis
negative regulation of morphogenesis of an
epithelium
negative regulation of prostatic bud formation
regulation of BMP signaling pathway
negative regulation of branching involved in ureteric
bud morphogenesis
animal organ formation
regulation of prostatic bud formation
regulation of morphogenesis of a branching structure
regulation of glomerulus development
metanephric renal vesicle morphogenesis
BMP signaling pathway
regulation of interleukin-6 production
carbohydrate:cation symporter activity
negative regulation of kidney development
testosterone 17-beta-dehydrogenase (NADP+)
activity
positive regulation of chemokine (C-X-C motif)
ligand 2 production
positive regulation of interleukin-6 production
peristalsis
nephron development
positive regulation of BMP signaling pathway

91
10
137
32

7
3
11
5

0.000751360618487751
0.000839410257077136
0.000849343536609647
0.000906591713866725

0.951641205696613
0.951641205696613
0.951641205696613
0.951641205696613
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Supplementary Table 12. Top 20 pathways from KEGG pathway analysis for CpGs included in the EPIC-PNA
NEOage clock.
Description
Vibrio cholerae infection
Endocrine and other factor-regulated calcium reabsorption
Aldosterone synthesis and secretion
Adipocytokine signaling pathway
Natural killer cell mediated cytotoxicity
Necroptosis
Adrenergic signaling in cardiomyocytes
Metabolism of xenobiotics by cytochrome P450
Salivary secretion
Other glycan degradation
Basal cell carcinoma
Arrhythmogenic right ventricular cardiomyopathy
Calcium signaling pathway
Cytokine-cytokine receptor interaction
Mineral absorption
GABAergic synapse
Viral protein interaction with cytokine and cytokine receptor
Growth hormone synthesis, secretion and action
Dilated cardiomyopathy
HIF-1 signaling pathway

path:hsa05110
path:hsa04961
path:hsa04925
path:hsa04920
path:hsa04650
path:hsa04217
path:hsa04261
path:hsa00980
path:hsa04970
path:hsa00511
path:hsa05217
path:hsa05412
path:hsa04020
path:hsa04060
path:hsa04978
path:hsa04727
path:hsa04061
path:hsa04935
path:hsa05414
path:hsa04066

N
49
51
95
66
118
147
144
74
86
18
63
74
228
278
54
84
97
116
92
105

DE
5
5
7
5
6.5
6
8
3
5
2
4
5
10.5
7
3
5
3.5
6
5
5

P.DE
0.0044303057296943
0.0130902253578704
0.0177978978310381
0.022338795028672
0.0315357173452436
0.0396709182209861
0.0399713503271485
0.0439232520019814
0.0473923210414602
0.0566603395732447
0.062286340491488
0.0666165663705422
0.0733984670436083
0.0823487304128945
0.0861725768552945
0.0868375944591549
0.0971045985176263
0.103216705086696
0.10503579562344
0.111209287977195

FDR
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Supplementary Table 13. Annotation of the 20 common CpGs of the NEOage clocks.
Name
cg05394010
cg04777726
cg24541835
cg05265234
cg21219851
cg00049440
cg01454951
cg21664351
cg12266861
cg07318287
cg04862002
cg00465247
cg01138164
cg13942103
cg21135560
cg01916724
cg05624226
cg13624964
cg17995197
cg06002476
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chr
chr16
chr19
chr1
chr22
chr17
chr9
chr3
chr11
chr1
chr1
chr17
chr13
chr7
chr1
chr8
chr3
chr5
chr14
chr2
chr3

pos
2546596
49340489
12651540
38884016
78898189
73026643
71730677
19841423
35449720
154377429
9074365
50703477
96648447
111177829
144946659
51975220
180325954
86088696
26408167
8617065

UCSC_RefGene_Name
TBC1D24
PLEKHA4;PLEKHA4;HSD17B14
DHRS3
DDX17;DDX17;DDX17;DDX17;DDX17;DDX17
RPTOR;RPTOR
KLF9
EIF4E3;EIF4E3;EIF4E3;EIF4E3
NAV2;NAV2;NAV2
IL6R;IL6R
NTN1

EPPK1
PARP3;PARP3;RRP9
BTNL8;BTNL8;BTNL8;BTNL8;BTNL8
FLRT2
FAM59B
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Supplementary Code
Please browse Full Text version to see the data of Supplementary Code 1.

Supplementary Code 1. R code example to calculate DNAm age using NEOage clocks.

www.aging-us.com

23544

AGING

